#merck
Human Papillomavirus Market Research Report 2025-2035, Competitive Analysis of Key Players - GlaxoSmithKline, Merck, and Serum Institute of India
The Human Papillomavirus (HPV) market is in a growth phase, driven by high vaccine adoption and innovative therapeutic strategies targeting HPV-related cancers like cervical and oropharyngeal. Key drivers include advancements in molecular diagnostics, next-ge…
Sun Pharma’s deal to buy Merck-spinoff Organon ticks the right box on acquisition cost if not R&D
Sun Pharma’s acquisition of US-based Organon looks like a financial bargain for the global scale and market access it offers. But the Indian drugmaker may need to look elsewhere for an R&D boost that could put it at the cutting edge of healthcare.